In-Vitro Toxicology/Toxicity Testing Market by Product & Services, Toxicity Endpoint & Test (Carcinogenicity, Dermal Toxicity), Technology (Cell-based, HTS), Method (Cellular Assays), Industry (Pharmaceutical, Cosmetics), Region-Global Forecast to 2024
“The global in-vitro toxicology testing market is projected to grow at a CAGR of 9.3%.”
The in-vitro toxicology testing market is expected to reach USD 12.7 billion by 2024 from an estimated USD 8.1 billion in 2019, at a CAGR of 9.3%. The opposition to animal testing, technological advancements, and increasing R&D expenditure to detect toxicity at an early stage during drug development are the primary growth factors for this industry. The increasing focus of the pharmaceutical and cosmetics industries on using in-vitro methods for product testing along with the improvement in silico methods for predictive toxicology studies are expected to offer significant growth opportunities for players in this market. However, the dearth of skilled professionals is a substantial market challenge.
“The software segment is expected to grow at the highest rate during the forecast period.”
Based on the product & service, the in-vitro toxicology testing market is segmented into consumables, assays, equipment, software, and services. The software segment is projected to witness the highest growth in the in-vitro toxicology testing market during the forecast period. Growth in this segment is driven mostly by the rising number of new technologies to develop in-vitro signatures and computational models capable of predicting in vivo responses. Also, the increasing use of the latest software in the industry and the academia to predict toxicity by comparing the data of new substances with other structurally or biologically similar compounds, are expected to drive the growth of this segment.
The ADME segment is expected to account for the largest market share in 2018.”
Based on toxicity endpoints & tests undertaken across all industries, the in-vitro toxicity testing market is segmented into ADME; skin irritation, corrosion, and sensitization; genotoxicity; cytotoxicity; ocular toxicity; organ toxicity; phototoxicity; dermal toxicity; and other endpoints & tests. The ADME segment accounted for the largest share of the in-vitro toxicity testing market in 2018. This can be attributed to the high adoption during the drug development process with the advantage of producing highly reproducible & accurate data.
“Toxicogenomics is expected to grow at the highest rate during the forecast period.”
The toxicogenomics segment is expected to grow at the highest CAGR during the forecast period, primarily due to the technological advancements taking place in the field of proteomics and genomics. Also, the improvements in proteomic technologies are enhancing the study of gene & protein activity during toxicity analysis. Technological advancements taking place in the field of proteomics and genomics will further drive the growth of this segment in the coming years.
“Europe is expected to hold the largest share for players operating in the in-vitro toxicology testing market.”
Europe accounted for the largest share of the in-vitro toxicology testing market in 2018. Factors such as high adoption of in-vitro toxicology testing assays and services in the cosmetics and chemical industries after the ban on animal testing in the region are among the few factors expected to contribute to the growth of this market.
A breakdown of the primary participants referred to for this report is provided below:
Research Coverage:
This report analyzes the market for various in-vitro toxicology testing products and their adoption patterns. It aims at estimating the market size and future growth potential of the global in-vitro toxicology testing market and its product & service, technology, toxicity endpoint & test, industry, method, and regional segments. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.
This report provides insights on the following pointers:
The in-vitro toxicology testing market is expected to reach USD 12.7 billion by 2024 from an estimated USD 8.1 billion in 2019, at a CAGR of 9.3%. The opposition to animal testing, technological advancements, and increasing R&D expenditure to detect toxicity at an early stage during drug development are the primary growth factors for this industry. The increasing focus of the pharmaceutical and cosmetics industries on using in-vitro methods for product testing along with the improvement in silico methods for predictive toxicology studies are expected to offer significant growth opportunities for players in this market. However, the dearth of skilled professionals is a substantial market challenge.
“The software segment is expected to grow at the highest rate during the forecast period.”
Based on the product & service, the in-vitro toxicology testing market is segmented into consumables, assays, equipment, software, and services. The software segment is projected to witness the highest growth in the in-vitro toxicology testing market during the forecast period. Growth in this segment is driven mostly by the rising number of new technologies to develop in-vitro signatures and computational models capable of predicting in vivo responses. Also, the increasing use of the latest software in the industry and the academia to predict toxicity by comparing the data of new substances with other structurally or biologically similar compounds, are expected to drive the growth of this segment.
The ADME segment is expected to account for the largest market share in 2018.”
Based on toxicity endpoints & tests undertaken across all industries, the in-vitro toxicity testing market is segmented into ADME; skin irritation, corrosion, and sensitization; genotoxicity; cytotoxicity; ocular toxicity; organ toxicity; phototoxicity; dermal toxicity; and other endpoints & tests. The ADME segment accounted for the largest share of the in-vitro toxicity testing market in 2018. This can be attributed to the high adoption during the drug development process with the advantage of producing highly reproducible & accurate data.
“Toxicogenomics is expected to grow at the highest rate during the forecast period.”
The toxicogenomics segment is expected to grow at the highest CAGR during the forecast period, primarily due to the technological advancements taking place in the field of proteomics and genomics. Also, the improvements in proteomic technologies are enhancing the study of gene & protein activity during toxicity analysis. Technological advancements taking place in the field of proteomics and genomics will further drive the growth of this segment in the coming years.
“Europe is expected to hold the largest share for players operating in the in-vitro toxicology testing market.”
Europe accounted for the largest share of the in-vitro toxicology testing market in 2018. Factors such as high adoption of in-vitro toxicology testing assays and services in the cosmetics and chemical industries after the ban on animal testing in the region are among the few factors expected to contribute to the growth of this market.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
- By Designation: C-level (35%), Director-level (25%), and Others (40%)
- By Region: North America (45%), Europe (30%), Asia Pacific (20%), Latin America (3%), and the Middle East & Africa (2%)
Research Coverage:
This report analyzes the market for various in-vitro toxicology testing products and their adoption patterns. It aims at estimating the market size and future growth potential of the global in-vitro toxicology testing market and its product & service, technology, toxicity endpoint & test, industry, method, and regional segments. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.
This report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global in-vitro toxicology testing market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the global in-vitro toxicology testing market
- Market Development: Comprehensive information on the lucrative emerging regions
- Market Diversification: Exhaustive information about the new product, growing geographies, and recent developments in the global in-vitro toxicology testing market
- Competitive Assessment: In-depth assessment of market ranking, growth strategies, revenue analysis, and services of leading players in the global in-vitro toxicology testing market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primaries
2.2 MARKET SIZE ESTIMATION
2.3 DATA TRIANGULATION APPROACH
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 IN VITRO TOXICOLOGY TESTING MARKET OVERVIEW
4.2 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD
4.3 IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION (2017–2024)
4.5 IN VITRO TOXICOLOGY TESTING MARKET: DEVELOPED VS. DEVELOPING MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 MARKET DRIVERS
5.2.1.1 Opposition to animal testing
5.2.1.2 Technological advancements
5.2.1.3 R&D on early-stage toxicity detection
5.2.2 MARKET RESTRAINTS
5.2.2.1 Reluctance of regulatory authorities to consider alternative methods for proving safety and efficacy
5.2.2.2 Failure to establish the intricacies of in vivo conditions
5.2.2.3 Lack of in vitro models to study complex endpoints
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Increasing focus on drug discovery and personalized medicine using in vitro methods
5.2.3.2 Increasing number of toxicology databases
5.2.4 MARKET CHALLENGES
5.2.4.1 Dearth of skilled professionals
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 INCREASING FOCUS ON PREDICTIVE TOXICOLOGY
6.3 SUPPLY CHAIN ANALYSIS
6.4 REGULATORY COMMITTEE ACTIVITIES
6.4.1 MAJOR STAKEHOLDERS
6.4.2 KEY INFLUENCERS
7 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE
7.1 INTRODUCTION
7.2 CONSUMABLES
7.2.1 CONSUMABLES TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD
7.3 ASSAYS
7.3.1 BACTERIAL TOXICITY ASSAYS
7.3.1.1 Bacterial assays dominate the market as they are the most widely adopted assay type across industries
7.3.2 ENZYME TOXICITY ASSAYS
7.3.2.1 Enzyme toxicity assays are increasingly used for endocrine-disrupting studies—a key factor driving market growth
7.3.3 CELL-BASED ELISA & WESTERN BLOTS
7.3.3.1 Cell-based assays are cost-effective, owing to which they are witnessing increasing adoption in drug discovery
7.3.4 RECEPTOR-BINDING ASSAYS
7.3.4.1 Receptor-binding assays are well-suited for high-throughput formats, a key factor driving the adoption of these products
7.3.5 TISSUE CULTURE ASSAYS
7.3.5.1 Tissue culture assays offer the advantage of mimicking in vivo tissue architecture
7.3.6 OTHER ASSAYS
7.4 EQUIPMENT
7.4.1 FULLY AUTOMATED EQUIPMENT IS WITNESSING GROWING ADOPTION IN RESEARCH
7.5 SOFTWARE
7.5.1 SOFTWARE TOOLS ARE VITAL IN REDUCING ANALYSIS TIMES AND MANAGING LARGE AMOUNTS OF DATA GENERATED IN OPERATIONS
7.6 SERVICES
7.6.1 LACK OF INFRASTRUCTURE AND EXPERTISE HAVE DRIVEN RELIANCE ON SERVICE PROVIDERS
8 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST
8.1 INTRODUCTION
8.2 ADME (ABSORPTION, DISTRIBUTION, METABOLISM, & EXCRETION) TESTING
8.2.1 ADME TESTING TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD
8.3 SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING
8.3.1 SKIN IRRITATION, CORROSION, AND SENSITIZATION ARE MAJOR ENDPOINTS STUDIED IN THE COSMETICS INDUSTRY
8.4 GENOTOXICITY TESTING
8.4.1 MORE GENOTOXICITY TESTS ARE REVIEWED AND VALIDATED BY REGULATORY AUTHORITIES THAN ANY OTHER ENDPOINT—A KEY DRIVER FOR MARKET GROWTH
8.5 CYTOTOXICITY TESTING
8.5.1 RISING NEED FOR BIOSAFETY IS LARGELY CONTRIBUTING TO THE GROWTH OF THE CYTOTOXICITY TESTING MARKET
8.6 OCULAR TOXICITY TESTING
8.6.1 IN VITRO AND EX VIVO METHODS ARE GAINING HIGH RECOGNITION FOR OCULAR TOXICITY TESTING
8.7 ORGAN TOXICITY TESTING
8.7.1 HIGH-CONTENT SCREENING AND CELL-BASED ASSAYS ARE USED TO DETECT ORGAN-SPECIFIC TOXICITY
8.8 PHOTOTOXICITY TESTING
8.8.1 VALIDATED NON-ANIMAL METHODS ARE USED TO EVALUATE THE PHOTOSAFETY OF COSMETICS, PHARMACEUTICALS, & CHEMICALS
8.9 DERMAL TOXICITY TESTING
8.9.1 IN VITRO METHODS FOR DERMAL TOXICITY TESTING ARE EXPECTED TO GAIN RECOGNITION IN THE COMING YEARS
8.10 OTHER TOXICITY ENDPOINTS & TESTS
9 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY
9.1 INTRODUCTION
9.2 CELL CULTURE TECHNOLOGIES
9.2.1 CELL- & TISSUE-BASED TECHNOLOGIES ARE THE MOST WIDELY ADOPTED IN IN VITRO TESTING
9.3 HIGH-THROUGHPUT TECHNOLOGIES
9.3.1 INCREASING USE OF HIGH-CONTENT IMAGING TECHNOLOGIES IS DRIVING MARKET GROWTH
9.4 TOXICOGENOMICS
9.4.1 IMPROVEMENTS IN PROTEOMIC TECHNOLOGIES ARE ENHANCING THE STUDY OF GENE & PROTEIN ACTIVITY DURING TOXICITY ANALYSIS
10 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY
10.1 INTRODUCTION
10.2 PHARMACEUTICALS & BIOPHARMACEUTICALS
10.2.1 DRUG ATTRITION RATE IS LEADING TO THE HIGH ADOPTION OF IN VITRO TESTING ASSAYS IN THE EARLY STAGES OF DRUG DEVELOPMENT
10.3 COSMETICS & HOUSEHOLD PRODUCTS
10.3.1 BAN ON ANIMAL TESTING IS INCREASING THE ADOPTION OF IN VITRO ASSAYS FOR SAFETY TESTING
10.4 FOOD
10.4.1 INCREASING FOCUS ON FOOD SAFETY IS DRIVING MARKET GROWTH
10.5 CHEMICALS
10.5.1 INCREASING FOCUS ON ORGANOID-BASED IN VITRO APPROACHES FOR CHEMICAL TESTING IS PROPELLING THE MARKET
11 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD
11.1 INTRODUCTION
11.2 CELLULAR ASSAYS
11.2.1 DEVELOPMENT OF MULTI-PARAMETER ASSAYS WILL PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES TO MARKET PLAYERS
11.3 BIOCHEMICAL ASSAYS
11.3.1 BIOCHEMICAL ASSAYS FIND WIDER APPLICATION IN THE PHARMACEUTICAL INDUSTRY AS COMPARED TO THE CHEMICAL AND FOOD INDUSTRIES
11.4 IN SILICO MODELS
11.4.1 IN SILICO MODELS ARE EXPECTED TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
11.5 EX VIVO MODELS
11.5.1 EX VIVO MODELS ARE WIDELY USED IN SKIN & EYE TOXICITY TESTING IN THE COSMETIC INDUSTRY
12 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION
12.1 INTRODUCTION
12.2 EUROPE
12.2.1 GERMANY
12.2.1.1 Germany holds the largest share of the European market
12.2.2 UK
12.2.2.1 Rising awareness, growing R&D, and increasing collaborations are key indicators of market growth in the UK
12.2.3 FRANCE
12.2.3.1 Research initiatives supported by the government are aiding market growth in France
12.2.4 ITALY
12.2.4.1 Growth in this market is mainly driven by the increasing life science R&D
12.2.5 SPAIN
12.2.5.1 Spain’s growing chemical industry is a major factor supporting the in vitro toxicology testing market in the country
12.2.6 REST OF EUROPE
12.3 NORTH AMERICA
12.3.1 US
12.3.1.1 The US dominates the North American in vitro toxicology testing market due to a growing focus on biomarker discovery and research in the field of structure-based drug design
12.3.2 CANADA
12.3.2.1 Strong support for R&D and focus on developing new therapies will support market growth in Canada
12.4 ASIA PACIFIC
12.4.1 CHINA
12.4.1.1 Increasing international pressure to ban animal testing methods will propel market growth in the coming years
12.4.2 JAPAN
12.4.2.1 Use of artificial skin patches and plates of cultured human cells has increased in Japan
12.4.3 INDIA
12.4.3.1 Growing CRAMs industry and the ban on the use of animals in cosmetics and universities are likely to propel market growth
12.4.4 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 LOW COST OF DRUG TRIALS HAVE MADE LATIN AMERICA A POPULAR OUTSOURCING MARKET
12.6 MIDDLE EAST & AFRICA
12.6.1 INCREASING R&D INVESTMENTS AND FOCUS ON THE DEVELOPMENT OF NEW DRUGS ARE CONTRIBUTING TO MARKET GROWTH
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 MARKET SHARE ANALYSIS
13.3 COMPETITIVE LEADERSHIP MAPPING
13.3.1 VISIONARY LEADERS
13.3.2 INNOVATORS
13.3.3 DYNAMIC DIFFERENTIATORS
13.3.4 EMERGING COMPANIES
13.4 COMPETITIVE SITUATION AND TRENDS
13.4.1 PRODUCT & SERVICE LAUNCHES
13.4.2 EXPANSIONS
13.4.3 ACQUISITIONS
13.4.4 OTHER STRATEGIES
14 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View)*
14.1 THERMO FISHER SCIENTIFIC, INC.
14.2 MERCK KGAA
14.3 EUROFINS SCIENTIFIC SE
14.4 GE HEALTHCARE
14.5 COVANCE, INC.
14.6 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
14.7 SGS S.A.
14.8 BIO-RAD LABORATORIES, INC.
14.9 QIAGEN N.V.
14.10 CYPROTEX PLC
14.11 PROMEGA CORPORATION
14.12 CATALENT, INC.
14.13 GENTRONIX LIMITED
14.14 MB RESEARCH LABORATORIES
14.15 BIOIVT
14.16 CREATIVE BIOLABS
14.17 GVK BIOSCIENCES PRIVATE LIMITED
14.18 SHANGHAI MEDICILON INC.
14.19 CREATIVE BIOARRAY
14.20 INSPHERO
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
15 APPENDIX
15.1 INSIGHTS OF INDUSTRY EXPERTS
15.2 DISCUSSION GUIDE
15.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.4 AVAILABLE CUSTOMIZATIONS
15.5 RELATED REPORTS
15.6 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY RESEARCH
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primaries
2.2 MARKET SIZE ESTIMATION
2.3 DATA TRIANGULATION APPROACH
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 IN VITRO TOXICOLOGY TESTING MARKET OVERVIEW
4.2 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD
4.3 IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION (2017–2024)
4.5 IN VITRO TOXICOLOGY TESTING MARKET: DEVELOPED VS. DEVELOPING MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 MARKET DRIVERS
5.2.1.1 Opposition to animal testing
5.2.1.2 Technological advancements
5.2.1.3 R&D on early-stage toxicity detection
5.2.2 MARKET RESTRAINTS
5.2.2.1 Reluctance of regulatory authorities to consider alternative methods for proving safety and efficacy
5.2.2.2 Failure to establish the intricacies of in vivo conditions
5.2.2.3 Lack of in vitro models to study complex endpoints
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Increasing focus on drug discovery and personalized medicine using in vitro methods
5.2.3.2 Increasing number of toxicology databases
5.2.4 MARKET CHALLENGES
5.2.4.1 Dearth of skilled professionals
6 INDUSTRY INSIGHTS
6.1 INTRODUCTION
6.2 INDUSTRY TRENDS
6.2.1 INCREASING FOCUS ON PREDICTIVE TOXICOLOGY
6.3 SUPPLY CHAIN ANALYSIS
6.4 REGULATORY COMMITTEE ACTIVITIES
6.4.1 MAJOR STAKEHOLDERS
6.4.2 KEY INFLUENCERS
7 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE
7.1 INTRODUCTION
7.2 CONSUMABLES
7.2.1 CONSUMABLES TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD
7.3 ASSAYS
7.3.1 BACTERIAL TOXICITY ASSAYS
7.3.1.1 Bacterial assays dominate the market as they are the most widely adopted assay type across industries
7.3.2 ENZYME TOXICITY ASSAYS
7.3.2.1 Enzyme toxicity assays are increasingly used for endocrine-disrupting studies—a key factor driving market growth
7.3.3 CELL-BASED ELISA & WESTERN BLOTS
7.3.3.1 Cell-based assays are cost-effective, owing to which they are witnessing increasing adoption in drug discovery
7.3.4 RECEPTOR-BINDING ASSAYS
7.3.4.1 Receptor-binding assays are well-suited for high-throughput formats, a key factor driving the adoption of these products
7.3.5 TISSUE CULTURE ASSAYS
7.3.5.1 Tissue culture assays offer the advantage of mimicking in vivo tissue architecture
7.3.6 OTHER ASSAYS
7.4 EQUIPMENT
7.4.1 FULLY AUTOMATED EQUIPMENT IS WITNESSING GROWING ADOPTION IN RESEARCH
7.5 SOFTWARE
7.5.1 SOFTWARE TOOLS ARE VITAL IN REDUCING ANALYSIS TIMES AND MANAGING LARGE AMOUNTS OF DATA GENERATED IN OPERATIONS
7.6 SERVICES
7.6.1 LACK OF INFRASTRUCTURE AND EXPERTISE HAVE DRIVEN RELIANCE ON SERVICE PROVIDERS
8 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST
8.1 INTRODUCTION
8.2 ADME (ABSORPTION, DISTRIBUTION, METABOLISM, & EXCRETION) TESTING
8.2.1 ADME TESTING TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD
8.3 SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING
8.3.1 SKIN IRRITATION, CORROSION, AND SENSITIZATION ARE MAJOR ENDPOINTS STUDIED IN THE COSMETICS INDUSTRY
8.4 GENOTOXICITY TESTING
8.4.1 MORE GENOTOXICITY TESTS ARE REVIEWED AND VALIDATED BY REGULATORY AUTHORITIES THAN ANY OTHER ENDPOINT—A KEY DRIVER FOR MARKET GROWTH
8.5 CYTOTOXICITY TESTING
8.5.1 RISING NEED FOR BIOSAFETY IS LARGELY CONTRIBUTING TO THE GROWTH OF THE CYTOTOXICITY TESTING MARKET
8.6 OCULAR TOXICITY TESTING
8.6.1 IN VITRO AND EX VIVO METHODS ARE GAINING HIGH RECOGNITION FOR OCULAR TOXICITY TESTING
8.7 ORGAN TOXICITY TESTING
8.7.1 HIGH-CONTENT SCREENING AND CELL-BASED ASSAYS ARE USED TO DETECT ORGAN-SPECIFIC TOXICITY
8.8 PHOTOTOXICITY TESTING
8.8.1 VALIDATED NON-ANIMAL METHODS ARE USED TO EVALUATE THE PHOTOSAFETY OF COSMETICS, PHARMACEUTICALS, & CHEMICALS
8.9 DERMAL TOXICITY TESTING
8.9.1 IN VITRO METHODS FOR DERMAL TOXICITY TESTING ARE EXPECTED TO GAIN RECOGNITION IN THE COMING YEARS
8.10 OTHER TOXICITY ENDPOINTS & TESTS
9 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY
9.1 INTRODUCTION
9.2 CELL CULTURE TECHNOLOGIES
9.2.1 CELL- & TISSUE-BASED TECHNOLOGIES ARE THE MOST WIDELY ADOPTED IN IN VITRO TESTING
9.3 HIGH-THROUGHPUT TECHNOLOGIES
9.3.1 INCREASING USE OF HIGH-CONTENT IMAGING TECHNOLOGIES IS DRIVING MARKET GROWTH
9.4 TOXICOGENOMICS
9.4.1 IMPROVEMENTS IN PROTEOMIC TECHNOLOGIES ARE ENHANCING THE STUDY OF GENE & PROTEIN ACTIVITY DURING TOXICITY ANALYSIS
10 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY
10.1 INTRODUCTION
10.2 PHARMACEUTICALS & BIOPHARMACEUTICALS
10.2.1 DRUG ATTRITION RATE IS LEADING TO THE HIGH ADOPTION OF IN VITRO TESTING ASSAYS IN THE EARLY STAGES OF DRUG DEVELOPMENT
10.3 COSMETICS & HOUSEHOLD PRODUCTS
10.3.1 BAN ON ANIMAL TESTING IS INCREASING THE ADOPTION OF IN VITRO ASSAYS FOR SAFETY TESTING
10.4 FOOD
10.4.1 INCREASING FOCUS ON FOOD SAFETY IS DRIVING MARKET GROWTH
10.5 CHEMICALS
10.5.1 INCREASING FOCUS ON ORGANOID-BASED IN VITRO APPROACHES FOR CHEMICAL TESTING IS PROPELLING THE MARKET
11 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD
11.1 INTRODUCTION
11.2 CELLULAR ASSAYS
11.2.1 DEVELOPMENT OF MULTI-PARAMETER ASSAYS WILL PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES TO MARKET PLAYERS
11.3 BIOCHEMICAL ASSAYS
11.3.1 BIOCHEMICAL ASSAYS FIND WIDER APPLICATION IN THE PHARMACEUTICAL INDUSTRY AS COMPARED TO THE CHEMICAL AND FOOD INDUSTRIES
11.4 IN SILICO MODELS
11.4.1 IN SILICO MODELS ARE EXPECTED TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
11.5 EX VIVO MODELS
11.5.1 EX VIVO MODELS ARE WIDELY USED IN SKIN & EYE TOXICITY TESTING IN THE COSMETIC INDUSTRY
12 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION
12.1 INTRODUCTION
12.2 EUROPE
12.2.1 GERMANY
12.2.1.1 Germany holds the largest share of the European market
12.2.2 UK
12.2.2.1 Rising awareness, growing R&D, and increasing collaborations are key indicators of market growth in the UK
12.2.3 FRANCE
12.2.3.1 Research initiatives supported by the government are aiding market growth in France
12.2.4 ITALY
12.2.4.1 Growth in this market is mainly driven by the increasing life science R&D
12.2.5 SPAIN
12.2.5.1 Spain’s growing chemical industry is a major factor supporting the in vitro toxicology testing market in the country
12.2.6 REST OF EUROPE
12.3 NORTH AMERICA
12.3.1 US
12.3.1.1 The US dominates the North American in vitro toxicology testing market due to a growing focus on biomarker discovery and research in the field of structure-based drug design
12.3.2 CANADA
12.3.2.1 Strong support for R&D and focus on developing new therapies will support market growth in Canada
12.4 ASIA PACIFIC
12.4.1 CHINA
12.4.1.1 Increasing international pressure to ban animal testing methods will propel market growth in the coming years
12.4.2 JAPAN
12.4.2.1 Use of artificial skin patches and plates of cultured human cells has increased in Japan
12.4.3 INDIA
12.4.3.1 Growing CRAMs industry and the ban on the use of animals in cosmetics and universities are likely to propel market growth
12.4.4 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 LOW COST OF DRUG TRIALS HAVE MADE LATIN AMERICA A POPULAR OUTSOURCING MARKET
12.6 MIDDLE EAST & AFRICA
12.6.1 INCREASING R&D INVESTMENTS AND FOCUS ON THE DEVELOPMENT OF NEW DRUGS ARE CONTRIBUTING TO MARKET GROWTH
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 MARKET SHARE ANALYSIS
13.3 COMPETITIVE LEADERSHIP MAPPING
13.3.1 VISIONARY LEADERS
13.3.2 INNOVATORS
13.3.3 DYNAMIC DIFFERENTIATORS
13.3.4 EMERGING COMPANIES
13.4 COMPETITIVE SITUATION AND TRENDS
13.4.1 PRODUCT & SERVICE LAUNCHES
13.4.2 EXPANSIONS
13.4.3 ACQUISITIONS
13.4.4 OTHER STRATEGIES
14 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View)*
14.1 THERMO FISHER SCIENTIFIC, INC.
14.2 MERCK KGAA
14.3 EUROFINS SCIENTIFIC SE
14.4 GE HEALTHCARE
14.5 COVANCE, INC.
14.6 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
14.7 SGS S.A.
14.8 BIO-RAD LABORATORIES, INC.
14.9 QIAGEN N.V.
14.10 CYPROTEX PLC
14.11 PROMEGA CORPORATION
14.12 CATALENT, INC.
14.13 GENTRONIX LIMITED
14.14 MB RESEARCH LABORATORIES
14.15 BIOIVT
14.16 CREATIVE BIOLABS
14.17 GVK BIOSCIENCES PRIVATE LIMITED
14.18 SHANGHAI MEDICILON INC.
14.19 CREATIVE BIOARRAY
14.20 INSPHERO
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
15 APPENDIX
15.1 INSIGHTS OF INDUSTRY EXPERTS
15.2 DISCUSSION GUIDE
15.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.4 AVAILABLE CUSTOMIZATIONS
15.5 RELATED REPORTS
15.6 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 2 IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 3 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 4 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 5 BACTERIAL TOXICITY ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 6 ENZYME TOXICITY ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 7 CELL-BASED ELISA & WESTERN BLOTS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 8 RECEPTOR-BINDING ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 9 TISSUE CULTURE ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 10 OTHER ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 11 IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 12 IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 13 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 14 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 15 ADME TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 16 SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 17 GENOTOXICITY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 18 CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 19 OCULAR TOXICITY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 20 ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 21 PHOTOTOXICITY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 22 DERMAL TOXICITY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 23 OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 24 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 25 IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE TECHNOLOGIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 26 IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT TECHNOLOGIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 27 IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 28 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 29 PHARMACEUTICAL & BIOPHARMACEUTICAL IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 30 COSMETIC & HOUSEHOLD PRODUCT IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 31 TYPES OF TOXICOLOGICAL TESTS IN THE FOOD INDUSTRY
TABLE 32 FOOD IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 33 CHEMICAL IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 34 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 35 IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 36 IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 37 IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 38 IN VITRO TOXICOLOGY TESTING MARKET FOR EX VIVO MODELS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 39 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 40 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 41 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 42 EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 43 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT &
TEST, 2017–2024 (USD MILLION)
TABLE 44 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 45 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 46 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 47 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT &
SERVICE, 2017–2024 (USD MILLION)
TABLE 48 GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 49 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 50 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 51 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 52 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 53 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 54 UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 55 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT &
TEST, 2017–2024 (USD MILLION)
TABLE 56 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 57 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 58 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 59 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 60 FRANCE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 61 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT &
TEST, 2017–2024 (USD MILLION)
TABLE 62 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 63 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 64 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 65 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 66 ITALY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 67 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT &
TEST, 2017–2024 (USD MILLION)
TABLE 68 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 69 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 70 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 71 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 72 SPAIN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 73 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT &
TEST, 2017–2024 (USD MILLION)
TABLE 74 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 75 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 76 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 77 ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 78 ROE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 79 ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 80 ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 81 ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 82 ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 83 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 84 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 85 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 86 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 87 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 88 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 89 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 90 US: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 91 US: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 92 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 93 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 94 US: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 95 US: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 96 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 97 CANADA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 98 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 99 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 100 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 101 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 102 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 103 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 104 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 105 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 106 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 107 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 108 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 109 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 110 CHINA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 111 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 112 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 113 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 114 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 115 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 116 JAPAN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 117 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 118 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 119 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 120 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 121 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 122 INDIA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 123 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 124 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 125 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 126 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 127 ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 128 ROAPAC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 129 ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 130 ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 131 ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 132 ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 133 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 134 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 135 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 136 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 137 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 138 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 139 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 140 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 141 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 142 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 143 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 144 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 145 PRODUCT & SERVICE LAUNCHES, 2017–2019
TABLE 146 EXPANSIONS, 2017–2019
TABLE 147 ACQUISITIONS, 2017–2019
TABLE 148 OTHER STRATEGIES, 2017–2019
TABLE 1 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 2 IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 3 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 4 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 5 BACTERIAL TOXICITY ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 6 ENZYME TOXICITY ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 7 CELL-BASED ELISA & WESTERN BLOTS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 8 RECEPTOR-BINDING ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 9 TISSUE CULTURE ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 10 OTHER ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 11 IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 12 IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 13 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 14 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 15 ADME TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 16 SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 17 GENOTOXICITY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 18 CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 19 OCULAR TOXICITY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 20 ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 21 PHOTOTOXICITY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 22 DERMAL TOXICITY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 23 OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 24 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 25 IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE TECHNOLOGIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 26 IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT TECHNOLOGIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 27 IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 28 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 29 PHARMACEUTICAL & BIOPHARMACEUTICAL IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 30 COSMETIC & HOUSEHOLD PRODUCT IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 31 TYPES OF TOXICOLOGICAL TESTS IN THE FOOD INDUSTRY
TABLE 32 FOOD IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 33 CHEMICAL IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 34 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 35 IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 36 IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 37 IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 38 IN VITRO TOXICOLOGY TESTING MARKET FOR EX VIVO MODELS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 39 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 40 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 41 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 42 EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 43 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT &
TEST, 2017–2024 (USD MILLION)
TABLE 44 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 45 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 46 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 47 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT &
SERVICE, 2017–2024 (USD MILLION)
TABLE 48 GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 49 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 50 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 51 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 52 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 53 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 54 UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 55 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT &
TEST, 2017–2024 (USD MILLION)
TABLE 56 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 57 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 58 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 59 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 60 FRANCE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 61 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT &
TEST, 2017–2024 (USD MILLION)
TABLE 62 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 63 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 64 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 65 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 66 ITALY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 67 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT &
TEST, 2017–2024 (USD MILLION)
TABLE 68 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 69 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 70 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 71 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 72 SPAIN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 73 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT &
TEST, 2017–2024 (USD MILLION)
TABLE 74 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 75 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 76 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 77 ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 78 ROE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 79 ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 80 ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 81 ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 82 ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 83 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 84 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 85 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 86 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 87 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 88 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 89 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 90 US: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 91 US: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 92 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 93 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 94 US: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 95 US: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 96 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 97 CANADA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 98 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 99 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 100 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 101 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 102 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 103 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 104 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 105 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 106 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 107 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 108 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 109 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 110 CHINA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 111 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 112 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 113 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 114 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 115 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 116 JAPAN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 117 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 118 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 119 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 120 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 121 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 122 INDIA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 123 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 124 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 125 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 126 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 127 ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 128 ROAPAC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 129 ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 130 ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 131 ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 132 ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 133 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 134 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 135 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 136 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 137 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 138 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 139 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 140 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 141 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 142 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 143 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 144 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 145 PRODUCT & SERVICE LAUNCHES, 2017–2019
TABLE 146 EXPANSIONS, 2017–2019
TABLE 147 ACQUISITIONS, 2017–2019
TABLE 148 OTHER STRATEGIES, 2017–2019
LIST OF FIGURES
FIGURE 1 IN VITRO TOXICOLOGY TESTING MARKET
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 MARKET SIZE APPROACH
FIGURE 5 BOTTOM-UP APPROACH
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019 VS. 2024 (USD MILLION)
FIGURE 8 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019 VS. 2024 (USD MILLION)
FIGURE 9 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019 VS. 2024 (USD MILLION)
FIGURE 10 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019 VS. 2024 (USD MILLION)
FIGURE 11 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019 VS. 2024 (USD MILLION)
FIGURE 12 GEOGRAPHIC ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET
FIGURE 13 OPPOSITION TO ANIMAL TESTING IS A MAJOR FACTOR DRIVING MARKET GROWTH
FIGURE 14 CELLULAR ASSAYS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC IN VITRO TOXICOLOGY TESTING MARKET IN 2018
FIGURE 15 CHINA SHOWS THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD
FIGURE 16 EUROPE WILL CONTINUE TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET IN 2024
FIGURE 17 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE IN THE FORECAST PERIOD
FIGURE 18 IN VITRO TOXICOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 19 SUPPLY CHAIN ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET
FIGURE 20 CONSUMABLES TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD
FIGURE 21 ORGAN TOXICITY TESTING TO REGISTER THE HIGHEST GROWTH IN THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD
FIGURE 22 TOXICOGENOMICS SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 23 PHARMACEUTICALS & BIOPHARMACEUTICALS TO COMMAND THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD
FIGURE 24 IN SILICO MODELS TO REGISTER THE HIGHEST GROWTH DURING
THE FORECAST PERIOD
FIGURE 25 IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC SNAPSHOT (2018)
FIGURE 26 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
FIGURE 27 TOTAL NUMBER OF CLINICAL TRIALS: GLOBAL VS. NORTH AMERICA (2017)
FIGURE 28 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
FIGURE 29 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
FIGURE 30 KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM
2017 TO AUGUST 2019
FIGURE 31 IN VITRO TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2018
FIGURE 32 IN VITRO TOXICOLOGY TESTING MARKET: COMPETITIVE LEADERSHIP
MAPPING (2018)
FIGURE 33 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2018)
FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2018)
FIGURE 35 EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2018)
FIGURE 36 GE HEALTHCARE: COMPANY SNAPSHOT (2018)
FIGURE 37 LABORATORY CORPORATION OF AMERICA HOLDINGS:
COMPANY SNAPSHOT (2018)
FIGURE 38 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.:
COMPANY SNAPSHOT (2018)
FIGURE 39 SGS S.A.: COMPANY SNAPSHOT (2018)
FIGURE 40 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2018)
FIGURE 41 QIAGEN N.V.: COMPANY SNAPSHOT (2018)
FIGURE 42 EVOTEC AG: COMPANY SNAPSHOT (2018)
FIGURE 43 CATALENT, INC.: COMPANY SNAPSHOT (2018)
FIGURE 1 IN VITRO TOXICOLOGY TESTING MARKET
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 MARKET SIZE APPROACH
FIGURE 5 BOTTOM-UP APPROACH
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2019 VS. 2024 (USD MILLION)
FIGURE 8 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2019 VS. 2024 (USD MILLION)
FIGURE 9 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2019 VS. 2024 (USD MILLION)
FIGURE 10 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2019 VS. 2024 (USD MILLION)
FIGURE 11 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2019 VS. 2024 (USD MILLION)
FIGURE 12 GEOGRAPHIC ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET
FIGURE 13 OPPOSITION TO ANIMAL TESTING IS A MAJOR FACTOR DRIVING MARKET GROWTH
FIGURE 14 CELLULAR ASSAYS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC IN VITRO TOXICOLOGY TESTING MARKET IN 2018
FIGURE 15 CHINA SHOWS THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD
FIGURE 16 EUROPE WILL CONTINUE TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET IN 2024
FIGURE 17 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE IN THE FORECAST PERIOD
FIGURE 18 IN VITRO TOXICOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 19 SUPPLY CHAIN ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET
FIGURE 20 CONSUMABLES TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD
FIGURE 21 ORGAN TOXICITY TESTING TO REGISTER THE HIGHEST GROWTH IN THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD
FIGURE 22 TOXICOGENOMICS SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 23 PHARMACEUTICALS & BIOPHARMACEUTICALS TO COMMAND THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD
FIGURE 24 IN SILICO MODELS TO REGISTER THE HIGHEST GROWTH DURING
THE FORECAST PERIOD
FIGURE 25 IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC SNAPSHOT (2018)
FIGURE 26 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
FIGURE 27 TOTAL NUMBER OF CLINICAL TRIALS: GLOBAL VS. NORTH AMERICA (2017)
FIGURE 28 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
FIGURE 29 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
FIGURE 30 KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM
2017 TO AUGUST 2019
FIGURE 31 IN VITRO TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2018
FIGURE 32 IN VITRO TOXICOLOGY TESTING MARKET: COMPETITIVE LEADERSHIP
MAPPING (2018)
FIGURE 33 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2018)
FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2018)
FIGURE 35 EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2018)
FIGURE 36 GE HEALTHCARE: COMPANY SNAPSHOT (2018)
FIGURE 37 LABORATORY CORPORATION OF AMERICA HOLDINGS:
COMPANY SNAPSHOT (2018)
FIGURE 38 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.:
COMPANY SNAPSHOT (2018)
FIGURE 39 SGS S.A.: COMPANY SNAPSHOT (2018)
FIGURE 40 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2018)
FIGURE 41 QIAGEN N.V.: COMPANY SNAPSHOT (2018)
FIGURE 42 EVOTEC AG: COMPANY SNAPSHOT (2018)
FIGURE 43 CATALENT, INC.: COMPANY SNAPSHOT (2018)
